Abstract
Much of what is known about the deleterious effects of tobacco use on health was learned from epidemiologic studies over the last half century. These studies establish unequivocally that tobacco use, particularly manufactured cigarette smoking, causes most cancers of the lung, oropharynx, larynx, and esophagus in the USA, and approximately one-third of all cancers of the pancreas, kidney, urinary bladder and uterine cervix. More recent evidence also implicates smoking with cancers of the stomach, liver and colorectum. While over half of the estimated 440 000 smoking-attributable deaths that occur annually in the USA involve non-malignant cardiovascular and respiratory conditions, smoking-attributable cancers are more recognized and feared. Geneticists increasingly study tobacco use as a model for environmental carcinogenicity. Tobacco-exposed populations provide opportunities to characterize the somatic mutations that give rise to specific cancers and to identify the inherited genetic traits that confer susceptibility or resistance. Studies to identify the genetic determinants of addiction may be particularly important. Future research to identify other susceptibility factors, such as genes that modify carcinogen metabolism or DNA repair, will need to be substantially larger and to quantify lifetime tobacco exposure with more precision than have past studies in order to distinguish gradations in risk due to exposure from those caused by genetic susceptibility. This review considers: (a) the epidemiology of tobacco use; (b) cancers presently classified as smoking-attributable by the US Surgeon General; (c) the magnitude of the epidemic of cancers and other diseases caused by tobacco use; (d) selected issues in the epidemiology of lung cancer; and (e) the interface of genetics and epidemiology in understanding, preventing, and treating tobacco-attributable disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahsan H, Neugut A, Gammon M . 1997 Cancer Epidemiol. Biomarkers Prev. 10: 779–782
Ambrosone C, Freudenheim J, Graham S, Marshall J, Vena J, Brasure J, Michalek A, Laughlin R, Nemoto T, Gillenwater K, Shield P . 1996 J. Am. Med. Assoc. 276: 1494–1501
Auerbach O, Garfinkel L . 1986 Digest. Dis. Sci. 31: 1014–1020
Auerbach O, Hammond C, Garfinkel L . 1979 N. Engl. J. Med. 300: 381–386
Auerbach O, Hammond E, Garfinkel L . 1970 Cancer 25: 92–104
Auerbach O, Stout A, Hammond E, Garfinkel L . 1961 N. Engl. J. Med. 265: 253–267
Auerbach O, Stout A, Hammond E, Garfinkel L . 1962 N. Engl. J. Med. 267: 119–125
Auerbach O, Stout A, Hammond E, Garfinkel L . 1964 Am. Rev. Resp. Dis. 90: 867–876
Auerbach O, Stout A, Hammond E, Garfinkel L . 1965 Arch. Environ. Health 11: 4–15
Baron J . 1996 Br. Med. Bull. 52: 58–73
Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K . 2000 Cancer Epidemiol. Biomarkers Prev. 9: 3–28
Bennett W, Alavanja M, Blomeke B, Vahakangas K, Castren K, Welsh J, Bowman ED, Khan MA, Flieder DB, Harris CC . 1999 J. Natl. Cancer Inst. 91: 2009–2014
Benowitz N . 2001 Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine Smoking and Tobacco Control Monograph No. 13. NIH Pub. No. 02-5074 U.S. Department of Health and Human Services, National Cancer Institute: Bethesda, MD
Benowitz N, Perez-Stable E, Herrera B, Jacob P . 2002 J. Natl. Cancer Inst. 94: 108–114
Bergen A, Caporaso N . 1999 J. Natl. Cancer Inst. 91: 1365–1375
Berkson J . 1955 Proceedings of the Staff Meetings of the Mayo Clinic 30: 319–348
Berkson J . 1958 J. Am. Stat. Assoc. 53: 28–38
Best E, Josie G, Walker C . 1961 Canad. J. Public Health 52: 99–106
Brockton N, Little J, Sharp L, Cotton S . 2000 Am. J. Epidemiol. 151: 846–861
Brownson R, Chang J, Davis J . 1992 Epidemiology 3: 61–64
Burns D, Lee L, Shen L, Gilpin E, Tolley H, Vaughn J, Shanks T . (eds) 1997 Cigarette smoking behavior in the United States National Institutes of Health: Bethesda, MD
Califano J, Leong P, Koch W, Eisenberger C, Sidransky D, Westra W . 1999 Clin. Cancer Res. 5: 1862–1867
Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D . 1996 Cancer Res. 56: 2488–2492
Califano J, Westra W, Meininger G, Corio R, Koch W, Sidransky D . 2000 Clin. Cancer Res. 6: 347–352
Cardon L, Bell J . 2001 Nature Reviews/Genetics 2: 91–99
Castelao J, Yuan J, Skipper P, Tannenbaum S, Gago-Dominguez M, Crowder J, Ross R, Yu M . 2001 J. Natl. Cancer Inst. 93: 538–545
CDC. 1997 MMWR 46: 1217–1220
CDC. 2002 MMWR 51: 300–303
Clemmesen J . 1965 Statistical studies in the Aetiology of Malignant Neoplasms. I. Review and Results. Copenhagen: Munksgaard
Cohn B, Wingard D, Cirillo P, Cohen R, Kaplan G . 1996 J. Natl. Cancer Inst. 88: 1867
Cooper E, Lamb F, Sanders E, Hirst E . 1932 J. Hygiene, London 32: 293–300
Corrao M, Guindon G, Cokkinides V, Sharma N . 2000a Bulletin of the World Health Organization 78: 884–890
Corrao M, Guindon G, Sharma N, Shokoohi D . 2000b Tobacco Control: Country Profiles American Cancer Society: Atlanta, GA
Cosma G, Crofts F, Currie D, Wirgin I, Toniolo P, Garte S . 1993 Cancer Epidemiol. Biomarkers Prev. 2: 53–57
Crofts F, Cosma G, Currie D, Taioli E, Toniolo P, Garte S . 1993 Carcinogenesis 14: 1729–1731
Croninger A, Graham E, Wynder E . 1958 Cancer Res. 18: 1263–1271
Denissenko M, Pao A, Tang M-S, Pfeifer G . 1996 Science 274: 430–432
Djordjevic M, Stellman S, Zang E . 2000 J. Natl. Cancer Inst. 92: 106–111
Doll R . 1996 Br. Med. Bull. 52: 35–49
Doll R . 1998 Stat. Methods Med. Res. 7: 87–117
Doll R, Hill A . 1950 Br. Med. J. 2: 739–748
Doll R, Hill A . 1954 Br. Med. J. 1: 1451–1455
Doll R, Hill A . 1956 Br. Med. J. 2: 1071–1081
Doll R, Hill A . 1964 Br. Med. J. 1: 1399–1410
Doll R, Hill A, Kreyberg L . 1957 Br. J. Cancer ii: 43–48
Doll R, Peto R . 1978 J. Epidemiol. Community Health 32: 303–313
Doll R, Peto R . 1981 J. Natl. Cancer Inst. 66: 1191–1308
Dorn H . 1959 Public Health Rep. 74: 581–593
Eberhardt M, Ingram D, Makuc D et al . 2001 Urban and Rural Health Chartbook. Health, United States, 2001 National Center for Health Statistics: Hyattsville, Maryland
Engelbreth-Holm J, Ahlmann J . 1957 Acta Pathalogical Microbiology Scandinavia 41: 267–272
Ford B . 1994 SmokeScreen – A guide to the personal risks and global effects of the cigarette habit North Perth, WA, Australia: Halcyon Press
Fraumeni J, Mason T . 1974 J. Natl. Cancer Inst. 52: 659–665
Gaffney M, Altshuler B . 1988 J. Natl. Cancer Inst. 80: 925–931
Gammon M, Schoenberg J, Ahsan H, Risch H, Vaughan T, Chow W, Rotterdam H, West A, Dubrow R, Stanford J, Mayne S, Farrow D, Niwa S, Blot W, Fraumeni Jr J . 1997 J. Natl. Cancer Inst. 89: 1277–1284
Garcia-Closas M, Lubin J . 1999 Am. J. Epidemiol. 149: 689–692
Garte S . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 1233–1237
Geisler S, Olshan A . 2001 Am. J. Epidemiol. 154: 95–105
Giovanucci E . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 725–731
Glantz S, Slade J, Bero L, Hanauer P, Barnes D . 1996 The Cigarette Papers Glantz S, Slade J, Bero L, Hanauer P, Barnes D. (eds) Berkeley USA: University of California Press pp 1–24
Green J, Banks E, Berrington A, Darby S, Deo H, Newton R . 2000 Br. J. Cancer 83: 412–417
Guerin M, Cuzin J . 1957 Bulletin of the Association of France Cancer 44: 387–408
Guo Z, Yamaguchi K, Sanchez-Cespedes M, Westra W, Koch W, Sidransky D . 2001 Clin. Cancer Res. 7: 1963–1968
Haenszel W, Shimkin M, Miller H . 1956 Public Health Monograph Number 45. PHS Pub. No. 463. Public Health Service U.S. Government Printing Office, 1956: Washington, D.C
Hammond E . 1966 Natl. Cancer Inst. Monogr. 19: 127–204
Hammond E, Horn D . 1958 JAMA 166: 1294–1308
Harris J . 1983 J. Natl. Cancer Inst. 71: 473–479
Harris R, Zang E, Anderson J, Wynder E . 1993 Int. J. Epidemiol. 22: 592–599
Heath A, Cates R, Martin N, Meyer J, Hewitt J, Neale M et al . 1995 Behavior genetic approaches in behavioral medicine Turner J, Cardon L, Hewitt J. (eds) New York: Plenum Press pp 45–66
Hecht S . 1999 J. Natl. Cancer Inst. 91: 1194–1210
Hecht S . 2000 J. Natl. Cancer Inst. 92: 782–783
Henningfield J, Cohen C, Pickworth W . 1993 Nicotine Addiction, Principles and Management Orleans C, Slade J. (eds) New York: Oxford University Press pp 24–45
Hickey K, Do K-A, Green A . 2001 Epidemiologic Reviews 23: 115–125
Hill A . 1965 Proc. Royal Soc. Med. 58: 295–300
Hopper J, Southey M, Dite G, Jolley D, Giles G, McCredie M, Easton D, Venter D, and Australian Breast Cancer Family Study . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 741–747
Houlston R . 1999 Cancer Epidemiol. Biomarkers Prev. 8: 675–682
IARC. 1986 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking International Agency for Reseach on Cancer: Lyon
IARC. 1987 IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Overall Evaluations of Carcinogenicity An Updating of IARC Monographs Volumes 1 to 42 International Agency for Reseach on Cancer: Lyon
Kahn H . 1966 Monograph 19, Epidemiological Study of Cancer and Other Chronic Diseases. Haenszel W. (ed.) U.S. Department of Health, Education, and Welfare, Public Health Service, National Cancer Institute: Bethesda, MD pp 1–126
King T, Brunetta P . 1999 N. Engl. J. Med. 341: 1231–1233
Kreyberg L . 1962 Acta Pathol. Microbiol. Immunol. Scand. Suppl. 157: 11–92
Lagergren J, Bergstrom R, Lindgren A, Nyren O . 2000 Int. J. Cancer 85: 340–346
Lam T, Ho S, Hedley A, Mak K, Peto R . 2001 BMJ 323: 361–362
Landi M, Sinha R, Lanh N, Kadlubar F . 1999 Metabolic Polymorphisms and Susceptibility to Cancer Vol. 148: Vineas P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P (eds) Lyon, France: IARC pp 173–195
Lang M, Pelkonen O . 1999 Metabolic Polymorphisms and Susceptilibity to Cancer Vol. 148: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds) Lyon, France: IARC Scientific Publications, International Agency for Research on Cancer pp 13–22
Law C, Day N, Chanmugaratnam K . 1976 Int. J. Cancer 17: 304–309
Lee J, Hong W, Hittelman W, Mao L, Lotan R, Shin D, Benner S, Xu X-C, Lee J, Papadimitrakopoulou V, Geyer C, Perez C, Martin J, El-Naggar A, Lippman S . 2000 Clin. Cancer Res. 6: 1702–1710
Leitch A . 1928 Fifth annual report of the British Empire Cancer Campaign London: British Empire Cancer Campaign pp 26
Levin M, Goldstein H, Gerhardt P . 1950 J. Am. Med. Assoc. 143: 336–338
Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Campbell TC, Chen JS . 1998 BMJ 317: 1411–1422
London S, Idle J, Daly A, Coetzee G . 1999 Lancet 353: 898–899
Lubin J, Blot W . 1984 J. Natl. Cancer Inst. 73: 383–389
Mabry M, Nelkin B, Baylin S . 1998 The Genetic Basis of Human Cancer. Vogelstein B, Kinzler K. (eds) New York: McGraw-Hill pp 671–679
Malone K, Daling J, Thompson J, O'Brien C, Francisco L, Ostrander E . 1998 JAMA 279: 922–929
Mao L, Lee J, Fan Y, Ro J, Batsakis J, Lippman S, Hittelman W, Hong W . 1996 Nat. Med. 2: 682–685
Martin G, Brown J, Eifler C, Houston G . 1999 J. Am. Dent. Assoc. 130: 945–954
Mattson M, Pollack E, Cullen J . 1987 Am. J. Public Health 77: 425–431
McDuffie H, Klassen D, Dossman J . 1991 J. Clin. Epidemiol. 44: 537–544
McGinnis J, Foege W . 1993 JAMA 270: 2207–2212
Mills C, Porter M . 1950 Cancer Res. 10: 539–542
Minna J, Roth J, Gazdar A . 2002 Cancer Cell 1: 49–52
Montesano R, Hainaut P, Hall J . 1997 Application of Biomarkers in Cancer Epidemiology Vol. 142: Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N. (eds) Lyon, France: IARC pp 291–301
Moolgavkar S, Luebeck G . 1990 Risk Analysis 10: 323–341
Murray C, Lopez A . 1997 Lancet 349: 1498–1504
Newman B, Mu H, Butler L, Millikan R, Moorman P, King M . 1998 JAMA 279: 915–921
Niu S-R, Yang G-H, Chen Z-M, Wang J-L, Wang G-H, He X-Z et al . 1998 BMJ 317: 1423–1424
Novotny T, Warner K, Kendrick J, Remington P . 1988 Am. J. Public Health 78: 1187–1189
Osann K, Anton-Culver H, Kurosaki T, Taylor T . 1993 Int. J. Cancer 54: 44–48
Passey R . 1929 Sixth report of British Empire Cancer Research Campaign British Empire Cancer Campaign: London p 85
Perera F . 1996 J. Natl. Cancer Inst. 88: 496–509
Perez-Stable E, Herrera B, Jacob III P, Benowitz N . 1998 JAMA 280: 152–156
Perneger T . 2001 J. Natl. Cancer Inst. 93: 1600–1602
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R . 2000 Br. Med. J. 321: 323–329
Peto R, Lopez A, Boreham J, Thun M, Heath Jr C . 1992 Lancet 339: 1268–1278
Peto R, Lopez A, Boreham J, Thun M, Heath CJ . 1994 Mortality from smoking in developed countries 1950–2000 New York: Oxford University Press
Peto R, Parish S, Gray R . 1985 Age-related factors in carcinogenesis Vol. 58: Likhachex A, Anisimov V, Montesano R. (eds) Lyon, France: IARC pp 43–53
Pike M, Doll R . 1965 Lancet 1: 665–668
Prescott E, Osler M, Hein H, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J . 1998 Epidemiology 79: 79–83
Ratnasinghe D, Yao S, Tangrea J, Qiao Y, Andersen M, Barrett M, Giffen C, Erozan Y, Tockman M, Taylor P . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 119–123
Richie JJ, Carmella S, Muscat J, Scott D . 1997 Cancer Epidemiol. Biomarkers Prev. 6: 783–790
Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L, Edwards B . 2001 SEER Cancer Statistics Review, 1973–1998 Bethesda, MD: National Cancer Institute
Risch H, Howe G, Jain M, Burch J, Holowaty E, Miller A . 1993 Am. J. Epidemiol. 138: 281–293
Roffo A . 1931 Zeitschrift fur Krebsforschung 33: 321–322
Rothman K, Greenland S . 1998 Modern Epidemiology. Philadelphia: Lippincott-Raven pp 7–28
Ryberg D, Hewer A, Phillips D, Haugen A . 1994 Cancer Res. 54: 5801–5803
Schrek R, Baker L, Ballard G, Dolgoff S . 1950 Cancer Res. 10: 49–58
Shields P, Caporaso N, Falk R, Sugimura H, Trivers G, Trump B, Hoover R, Weston A, Harris C . 1993 Cancer Epidemiol. Biomarkers Prev. 2: 481–485
Shriver S, Bourdeau H, Gubish C, Tirpak D, Gaither Davis A, Luketich J, Siegfried J . 2000 J. Natl. Cancer Inst. 92: 24–33
Sidransky D . 1995 Monogr. Natl. Cancer Inst. 17: 27–29
Silverman S . 1998 Oral Cancer. Hamilton: B.C. Decker Inc pp 25–40
Slade J . 1993 Nicotine Addiction, Principles and Management Orleans C, Slade J. (eds) New York: Oxford University Press pp 3–23
Smith S, Fiore M . 1999 Primary Care 26: 433–461
Sommering S . 1795 De morbis vasorum absorbentium corporis humani Frankfurt: Varrentrapp & Wenner
Spivack S, Fasco M, Walker V, Kaminsky L . 1997 Criti. Rev. Toxicol. 27: 319–365
Stellman S, Takezaki T, Wang L, Chen Y, Citron M, Djordjevic M, Harlap S, Muscat J, Neugut A, Wynder E, Oqawa H, Tajima K, Aoki K . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 1193–1199
Stern M, Umbach D, van Gils C, Lunn R, Taylor J . 2001 Cancer Epidemiol. Biomarkers Prev. 10: 125–131
Stewart J . 2001 Cancer 91: 2476–2482
Strange R, Fryer A . 1999 Metabolic Polymorphisms and Suseptilibity to Cancer Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P. (eds) Lyon, France: IARC Scientific Publications No. 148. International Agency for Research on Cancer pp 231–249
Straub R, Sullivan P, Ma Y, Myakishev M, Harris-Kerr C, Wormley B, Kadambi B, Sadek H, Silverman MA, Webb BT, Neale MC, Bulik CM, Joyce PR, Kandler KS . 1999 Mol. Psychiatry 4: 129–144
Strong L, Amos C . 1996 Cancer Epidemiology and Prevention Schottenfeld D, Fraumeni J. (eds) New York: Oxford University Press pp 559–583
Struewing J, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, Timmerman M, Brody L, Tucker M . 1997 N. Engl. J. Med. 336: 1401–1408
Sugiura K . 1956 Gann. 47: 243–244
Taioli E, Ford J, Trachman J, Li Y . 1998 Carcinogenesis 19: 813–817
Thun M . 1998 Tobacco Control 7: 223–226
Thun M, Calle E, Rodriguez C, Wingo P . 2000 Cancer Epidemiol. Biomarkers Prev. 9: 861–868
Thun M, Day-Lally C, Meyers D, Calle E, Flanders W, Namboodiri M, Heath C . 1997a Monograph 8 In Changes in Cigarette-related Disease Risks and Their Implication for Prevention and Control Burns D, Garfinkel L, Samet J. (eds) Bethesda, MD: National Institutes of Health
Thun M, Day-Lally C, Myers D, Calle E, Flanders W, Zhu B, Namboodiri M, Heath CJ . 1997b National Cancer Institute, Smoking and Tobacco Control, Monograph 8: Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. NIH Publication No. 97-4213 Washington, DC: National Institutes of Health pp. 305–382
Thun M, Lally C, Flannery J, Calle E, Flanders W, Heath C . 1997c J. Natl. Cancer Inst. 89: 1580–1586
Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A . 1997 Int. J. Cancer 72: 565–573
US Department of Agriculture. 2001 US Department of Agriculture, Commodity Economics Division Research Service: Washington, D.C
US Department of Health and Human Services. 1988 Reducing the Health Consequences of Smoking: 25 Years of Progress: A Report of the Surgeon General US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD
US Department of Health and Human Services. 1989 The Health Benefits of Smoking Cessation: A Report of the Surgeon General US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Rockville, MD
US Department of Health and Human Services. 1990 Nicotine Addiction. A Report of the Surgeon General DHHS Publication No. (CDC) 88-8406: Rockville, MD
US Public Health Service. 1964 Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service US Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control: Washington, DC
Wakai K, Seki N, Tamakoshi A, Kondo T, Nishino Y, Ito Y, Suzuki K, Ozasa K, Watanabe Y, Ohno Y and et al . 2001 Jpn. J. Cancer Res. 92: 821–828
Weinberg C, Sandler D . 1999 J. Natl. Cancer Inst. 91: 1985–1986
Westra W, Sidransky D . 1998 J. Natl. Cancer Inst. 90: 1500–1501
Wu-Williams A, Samet J . 1994 Epidemiology of Lung Cancer Samet J (ed.) New York: Marcel Dekker, Inc pp 71–108
Wynder E, Graham E . 1950 J. Am. Med. Assoc. 143: 329–336
Wynder E, Graham E, Croninger A . 1953 Cancer Res. 13: 855–864
Wynder E, Graham E, Croninger A . 1955 Cancer Res. 15: 445–448
Yuan J-M, Ross R, Wang X-L, Gao Y-T, Henderson B, Yu M . 1996 JAMA 275: 1646–1650
Zang E, Wynder E . 1992 Cancer 70: 69–76
Zang E, Wynder E . 1996 J. Natl. Cancer Inst. 88: 183–192
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thun, M., Henley, S. & Calle, E. Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21, 7307–7325 (2002). https://doi.org/10.1038/sj.onc.1205807
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205807
Keywords
This article is cited by
-
Apparent changes in the epidemiology and severity of multiple sclerosis
Nature Reviews Neurology (2021)
-
Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study
Infectious Agents and Cancer (2019)
-
Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx
Scientific Reports (2019)
-
CYP1A1 Ile462Val Polymorphism as a Risk Factor in Cervical Cancer Development in the Polish Population
Molecular Diagnosis & Therapy (2014)
-
Exposure to environmental tobacco smoke (ETS) and risk of lung cancer in Montreal: a case–control study
Environmental Health (2013)